GlaxoSmithKline Research Chooses Spotfire
Complete the form below to unlock access to ALL audio articles.
Spotfire has announced that GSK has selected Spotfire DecisionSite® across its Chemistry Domain area to assist the discovery and development of products and processes.
Spotfire was selected because its analytics and visualization solutions can handle large amounts of complex data, address a range of analytic challenges and serve a broad number of researchers in understanding multiple sources of research material and information.
Because of its customizable and scaleable attributes, Spotfire DecisionSite was chosen by the IT team within GSK"s Chemistry Domain over other analytic solutions available in the market.
In addition to its strength in visualizing and analyzing data, DecisionSite has also allowed GSK’s Chemistry Domain to work with the large volume of high throughput data coming from its screening program.
GSK’s Chemistry Domain has worked closely with Spotfire’s professional services team to develop custom analytic solutions to meet some of the specific research analytic challenges.
Commenting on GSK’s use of the DecisionSite solution, Christopher Ahlberg, CEO of Spotfire, said, "GSK researchers use interactive analytics to gain insights that can improve medical care for people everywhere."
"The fact that they chose us is both an honor and a great example of how Spotfire is able to help professionals in many fields illuminate important and exciting discoveries amongst the overwhelming amount of information we often work with."
